An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Ajj, Hussein ^a   Chesnel, Amand ^a   Pinel, Sophie ^a   Plenat, François ^a   Flament, Stephane ^a   Dumond, Helene ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 NONYLPHENOL; 4 TERT OCTYLPHENOL; ALKYLPHENOL; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; 4-NONYLPHENOL; 4-TERT-OCTYLPHENOL; ANDROSTANE DERIVATIVE; CARCINOGEN; CREB1 PROTEIN, MOUSE; DNA (CYTOSINE 5) METHYLTRANSFERASE; ISOPROTEIN; PHENOL DERIVATIVE; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYONAL CARCINOMA; GENE SILENCING; GENE TARGETING; GENETIC TRANSDUCTION; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; MULTIGENE FAMILY; NONHUMAN; NUDE MOUSE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SEMINOMA; SIGNAL TRANSDUCTION; TESTIS CANCER; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CARCINOMA; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; TESTIS TUMOR;

MUS MUSCULUS;

ANDROSTADIENES; ANIMALS; CARCINOGENS, ENVIRONMENTAL; CARCINOMA; CELL PROLIFERATION; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; EPIGENESIS, GENETIC; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN ISOFORMS; SEMINOMA; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS;

EID: 84876543264     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061758     Document Type: Article

References (58)

1. Vega A, Baptissart M, Caira F, Brugnon F, Lobaccaro JM, et al. (2012) Epigenetic, a molecular link between testicular cancer and environmental exposures. Front Endocrinol (Lausanne) 3: 150 doi:10.3389/fendo.2012.00150.
2. Skakkebaek NE, (1975) Atypical germ cells in the adjacent "normal" tissue of testicular tumours. Acta Pathol Microbiol Scand A 83: 127-130.
3. Sonne SB, Almstrup K, Dalgaard M, Juncker AS, Edsgard D, et al. (2009) Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 69: 5241-5250.
4. Rajpert-De Meyts E, Hoei-Hansen CE, (2007) From gonocytes to testicular cancer: the role of impaired gonadal development. Ann NY Acad Sci 1120: 168-180.
5. Beiki O, Granath F, Allebeck P, Akre O, Moradi T, (2010) Subtype-specific risk of testicular tumors among immigrants and their descendants in Sweden, 1960 to 2007. Cancer Epidemiol Biomarkers Prev 19: 1053-1065.
6. Cyriac S, Rajendranath R, Louis AR, Sagar TG, (2012) Familial germ cell tumor. Indian J Hum Genet 18: 119-121.
7. Main KM, Skakkebaek NE, Virtanen HE, Toppari J, (2010) Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 24: 279-289.
8. Skakkebaek NE, Rajpert-De Meyts E, Main KM, (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16: 972-978.
9. Thomas P, Dong J, (2006) Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J Steroid Biochem Mol Biol 102: 175-179.
10. Calafat AM, Kuklenyik Z, Reidy JA, Caudill SP, Ekong J, et al. (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113: 391-395.
11. Müller S, Schmid P, Schlatter C, (1998) Pharmacokinetic behavior of 4-nonylphenol in humans. Environ Toxicol Pharmacol 5: 257-265.
12. McClusky LM, de Jager C, Bornman MS, (2007) Stage-related increase in the proportion of apoptotic germ cells and altered frequencies of stages in the spermatogenic cycle following gestational, lactational, and direct exposure of male rats to p-nonylphenol. Toxicol Sci 95: 249-256.
13. Fucic A, Gamulin M, Ferencic Z, Katic J, Krayer von Krauss M, et al. (2012) Environmental exposure to xenoestrogens and oestrogen related cancers: reproductive system, breast, lung, kidney, pancreas, and brain. Environ Health 11Suppl 1: S8.
14. Bouskine A, Nebout M, Brücker-Davis F, Benahmed M, Fenichel P, (2009) Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ Health Perspect 117: 1053-1058.
15. Chevalier N, Vega A, Bouskine A, Siddeek B, Michiels JF, et al. (2012) GPR30, the non-classical membrane G protein related estrogen receptor, is overexpressed in human seminoma and promotes seminoma cell proliferation. PLoS One 7: e34672.
16. Li Z, Zhang H, Gibson M, Li J, (2012) An evaluation on combination effects of phenolic endocrine disruptors by estrogen receptor binding assay. Toxicol In Vitro 26: 769-774.
17. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, et al. (2005) Identification, cloning, and expression of human estrogen receptor-alpha 36, a novel variant of human estrogen receptor-alpha 36. Biochem Biophys Res Commun 336: 1023-1027.
18. Tong JS, Zhang QH, Wang ZB, Li S, Yang CR, et al. (2010) ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway. PLoS One 5: e15408.
19. Wallacides A, Chesnel A, Ajj H, Chillet M, Flament S, et al. (2012) Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERalpha induction. Mol Cell Endocrinol 350: 61-71.
20. Zhang XT, Ding L, Kang LG, Wang ZY, (2012) Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells. Oncol Rep 27: 2057-2065.
21. Kang L, Zhang X, Xie Y, Tu Y, Wang D, et al. (2010) Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling. Mol Endocrinol 24: 709-721.
22. Wang L, Wang ZY, (2010) The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells. Oncol Rep 23: 1109-1117.
23. Zhang XT, Kang LG, Ding L, Vranic S, Gatalica Z, et al. (2011) A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells. Oncogene 30: 770-780.
24. Mizuno Y, Gotoh A, Kamidono S, Kitazawa S, (1993) Establishment and characterization of a new human testicular germ cell tumor cell line (TCam-2). Nihon Hinyokika Gakkai Zasshi 84: 1211-1218.
25. Raecker T, Thiele B, Boehme RM, Guenther K, (2011) Endocrine disrupting nonyl- and octylphenol in infant food in Germany: considerable daily intake of nonylphenol for babies. Chemosphere 82: 1533-1540.
26. Prossnitz ER, Barton M, (2011) The G-protein-coupled estrogen receptor GPER in health and disease. Nat Rev Endocrinol 7: 715-726.
27. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, et al. (2006) A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 103: 9063-9068.
28. Long F, Liu H, Hahn C, Sumazin P, Zhang MQ, et al. (2004) Genome-wide prediction and analysis of function-specific transcription factor binding sites. In Silico Biol 4: 395-410.
29. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL, (2000) Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci 54: 154-167.
30. Willoughby KN, Sarkar AJ, Boyadjieva NI, Sarkar DK, (2005) Neonatally administered tert-octylphenol affects onset of puberty and reproductive development in female rats. Endocrine 26: 161-168.
31. Kilian E, Delport R, Bornman MS, de Jager C, (2007) Simultaneous exposure to low concentrations of dichlorodiphenyltrichloroethane, deltamethrin, nonylphenol and phytoestrogens has negative effects on the reproductive parameters in male Spraque-Dawley rats. Andrologia 39: 128-135.
32. Dobrzyńska MM, (2012) Male-mediated F1 effects in mice exposed to nonylphenol or to a combination of X-rays and nonylphenol. Drug Chem Toxicol 35: 36-42.
33. Frassinetti S, Barberio C, Caltavuturo L, Fava F, Di Gioia D, (2011) Genotoxicity of 4-nonylphenol and nonylphenol ethoxylate mixtures by the use of Saccharomyces cerevisiae D7 mutation assay and use of this text to evaluate the efficiency of biodegradation treatments. Ecotoxicol Environ Saf 74: 253-258.
34. Pupo M, Pisano A, Lappano R, Santolla MF, De Francesco EM, et al. (2012) Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts. Environ Health Perspect 120: 1177-1182.
35. Barton M, (2012) The membrane estrogen receptor GPER- Clues and questions. Steroids 77: 935-942.
36. Berner C, Aumüller E, Gnauck A, Nestelberger M, Just A, et al. (2010) Epigenetic control of estrogen receptor expression and tumor suppressor genes is modulated by bioactive food compounds. Ann Nutr Metab 57: 183-189.
37. Anway MD, Rekow SS, Skinner MK, (2008) Transgenerational epigenetic programming of the embryonic testis transcriptome. Genomics 91: 30-40.
38. Liao HF, Tai KY, Chen WS, Cheng LC, Ho HN, et al. (2012) Functions of DNA methyltransferase 3-like in germ cells and beyond. Biol Cell 104: 571-587.
39. Sun MY, Yang XX, Xu WW, Yao GY, Pan HZ, et al. (2012) Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China. Genet Mol Res 11: 4330-4341.
40. Yang XX, He XQ, Li FX, Wu YS, Gao Y, et al. (2012) Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the southern chinese population. Int J Mol Sci 13: 8364-8378.
41. Borghese B, Santulli P, Héquet D, Pierre G, de Ziegler D, et al. (2012) Genetic polymorphisms of DNMT3L involved in hypermethylation of chromosomal ends are associated with greater risk of developing ovarian endometriosis. Am J Pathol 180: 1781-1786.
42. Kristensen DG, Mlynarska O, Nielsen JE, Jacobsen GK, Rajpert-De Meyts E, et al. (2012) Heterogeneity of chromatin modifications in testicular spermatocytic seminoma point toward an epigenetically unstable phenotype. Cancer Genet 205: 425-431.
43. Okamoto K, (2012) Epigenetics: a way to understand the origin and biology of testicular germ cell tumors. Int J Urol 19: 504-511.
44. Ushida H, Kawakami T, Minami K, Chano T, Okabe H, et al. (2012) Methylation profile of DNA repetitive elements in human testicular germ cell tumor. Mol Carcinog 51: 711-722.
45. Beyrouthy MJ, Garner KM, Hever MP, Freemantle SJ, Eastman A, et al. (2009) High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. Cancer Res 69: 9360-9366.
46. Biswal BK, Beyrouthy MJ, Hever-Jardine MP, Armstrong D, Tomlinson CR, et al. (2012) Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One 7: e53003.
47. Zhang X, Odom DT, Koo SH, Conkright MD, Canettieri G, et al. (2005) Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102: 4459-4464.
48. Hervouet E, Vallette FM, Cartron PF, (2009) Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation. Epigenetics 4: 487-499.
49. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, et al. (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113: 6411-6418.
50. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, et al. (2007) Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 77: 681-687.
51. Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, et al. (2005) Survey of differentially methylated promoters in prostate cancer cell lines. Neoplasia 7: 748-760.
52. Imura M, Yamashita S, Cai LY, Furuta J, Wakabayashi M, et al. (2006) Methylation and expression analysis of 15 genes and three normally-methylated genes in 13 Ovarian cancer cell lines. Cancer Lett 241: 213-220.
53. Anway MD, Leathers C, Skinner MK, (2006) Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology 147: 5515-5523.
54. Minami K, Chano T, Kawakami T, Ushida H, Kushima R, et al. (2010) DNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma. Clin Cancer Res 16: 2751-2759.
55. Bourc'his D, Bestor TH, (2004) Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature 431: 96-99.
56. Chédin F, (2011) The DNMT3 family of mammalian de novo DNA methyltransferases. Prog Mol Biol Transl Sci 101: 255-285.
57. Walton EL, Francastel C, Velasco G, (2011) Maintenance of DNA methylation: Dnmt3b joins the dance. Epigenetics 6: 1373-1377.
58. Hashimoto H, Vertino PM, Cheng X, (2010) Molecular coupling of DNA methylation and histone methylation. Epigenomics 2: 657-669.